I131 reinforces antitumor activity of metuximab by reversing epithelial–mesenchymal transition via VEGFR‐2 signaling in hepatocellular carcinoma

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2443|23|1|35-45

ISSN: 1356-9597

Source: GENES TO CELLS, Vol.23, Iss.1, 2018-01, pp. : 35-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content